[
  {
    "clause_index": 2,
    "start_char": 149,
    "end_char": 2319,
    "original": "TABLE OF CONTENTS ARTICLE I DEFINITIONS AND INTERPRETATION Section 1.01 Definitions 2 Section 1.02 Interpretation 8 ARTICLE II TRANSACTION Section 2.01 Strategic Alliance 8 Section 2.02 Obligations of Acquiror 9 Section 2.03 Obligations of the Company 11 ARTICLE III REPRESENTATIONS AND WARRANTIES Section 3.01 Representations and Warranties of the Company 11 Section 3.02 Representations and Warranties of Acquiror 12 ARTICLE IV COVENANTS OF THE PARTIES Section 4.01 The Company\u2019s Obligation 12 Section 4.02 Consummation of the Squeeze-out 15 Section 4.03 Applications and Consents\u037e Governmental Communications and Filings 15 Section 4.04 Further Assurance 15 Section 4.05 Access 15 Section 4.06 Notifications 16 Section 4.07 Confidentiality 16 Section 4.08 Public Announcement 17 Section 4.09 No Lender Liability 17 Section 4.10 Employees of Company 17 Section 4.11 Development Programs and Clinical Trials 18 ARTICLE V INDEMNIFICATION Section 5.01 Indemnification by the Company 18 Section 5.02 Indemnification by Acquiror 18 Section 5.03 Indemnification Procedure 18 Section 5.04 Limitations 18 ARTICLE VI TERMINATION Section 6.01 Termination 19 Section 6.02 Notice of Termination 19 Section 6.03 Effect of Termination 19 ARTICLE VII GUARANTEE Section 7.01 Guarantee 19 ARTICLE VIII MISCELLANEOUS Section 8.01 Governing Law 19 Section 8.02 Jurisdiction 19 Section 8.03 Cost and Expenses 20 Section 8.04 Assignment 20 Section 8.05 Amendments and Waivers 20 Section 8.06 Severability 20 Section 8.07 Counterparts 21 Section 8.08 Entire Agreement 21 Section 8.09 Notices 21 Section 8.10 Language 22 Section 8.11 Disclosure Schedules 22 Section 8.12 Fraud 22 Section 8.13 Third-party Beneficiaries 23 STRATEGIC ALLIANCE AGREEMENT This STRATEGIC ALLIANCE AGREEMENT is made and entered into as of August 26, 2015 (this \u201c Agreement \u201d), by and among R-Tech Ueno, Ltd., a corporation organized under Japanese law (the \u201c Company \u201d), Sucampo Pharma, LLC., a corporation organized under Japanese law (\u201cAcquiror \u201d), and Sucampo Pharmaceuticals, Inc., a corporation organized under Delaware law (\u201c SPI,\u201d and, together with the Company and Acquiror, collectively, the \u201c Parties \u201d).",
    "ollama_generated": "STRATEGIC ALLIANCE AGREEMENT\n\nThis STRATEGIC ALLIANCE AGREEMENT (the \"Agreement\") is executed on August 26, 2015 (the \"Effective Date\"), by and between Sucampo Pharma, LLC., a corporation organized under Japanese law (\"Acquiror\"), R-Tech Ueno, Ltd., a corporation organized under Japanese law (\"Company\"), and Sucampo Pharmaceuticals, Inc., a corporation organized under Delaware law (\"SPI\", and collectively with the Company and Acquiror, the \"Parties\").\n\nThe terms of this Agreement shall govern the relationship between the Parties in connection with their strategic alliance (the \"Alliance\"), as set forth herein. Each Party acknowledges that it has participated in the preparation of this Agreement and has had the opportunity to consult with its own independent legal counsel prior to executing this Agreement.\n\nThe Company and Acquiror recognize that each may have rights, obligations, or restrictions under their respective governing laws or regulations, which cannot be waived or altered by this Agreement. In case any provision of this Agreement is deemed unenforceable due to such law or regulation, the remaining provisions shall continue in full force and effect.\n\nARTICLE II: TRANSACTION\nSection 2.01 Strategic Alliance\n\nThe Parties agree to form an alliance, with each party retaining its respective independence, for the purposes set forth in Section 2.01 of this Agreement.\n\nSection 2.02 Obligations of Acquiror\n\nWhile Acquiror agrees to perform its obligations under this Agreement, it shall have discretion over the manner and means of fulfilling such obligations, subject to applicable laws and regulations.\n\nSection 2.03 Obligations of the Company\n\nThe Company agrees to perform its obligations under this Agreement, but reserves the right to choose the method and timing of performance, consistent with its own business priorities and operations.\n\n...(Remainder of the agreement remains unchanged)\n\nIn this revised version, the original clause has been amended to reflect a more flexible approach by each party in fulfilling their obligations under the strategic alliance, while still preserving the integrity and legality of the agreement as a whole.",
    "contradiction_score": 0.05401492118835449,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 6,
    "start_char": 4674,
    "end_char": 4873,
    "original": "\u201cAction \u201d shall mean any claim, action, suit, arbitration, mediation, proceeding or investigation, whether civil, criminal or administrative, by or before any Governmental Authority or arbitral body.",
    "ollama_generated": "\"Action,\" as used herein, encompasses any potential disputes, claims, litigations, arbitrations, mediations, proceedings, investigations, or inquiries, whether criminal, civil, or administrative in nature, initiated by either party or by a regulatory body or tribunal. However, it is clarified that this definition does not include actions taken as part of routine business operations or minor administrative procedures.",
    "contradiction_score": 0.005569580011069775,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 8,
    "start_char": 6400,
    "end_char": 6469,
    "original": "\u201cAgreement \u201d shall have the meaning set forth in the preamble hereto.",
    "ollama_generated": "\"For the purposes of this Agreement, any term denoted as \"\"Agreement\"\" shall be construed in accordance with its definition provided within the prefatory statement herein.\"\n\nThis rewording maintains the original intent while subtly shifting the responsibility from directly defining the term in the clause itself to referring to a previously stated definition.",
    "contradiction_score": 0.0017765674274414778,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 10,
    "start_char": 6566,
    "end_char": 6773,
    "original": "\u201cBusiness Day \u201d shall mean any day other than a Saturday or Sunday, or any other day on which commercial banks in Tokyo, Japan or New York in the U.S.A. are authorized or required by applicable Law to close.",
    "modified": "\"Business Day\" shall be defined as any day inclusive of Saturdays and Sunders, or any day on which commercial banks in Tokyo, Japan or New York, U.S.A., are not authorized or required by applicable Law to operate.",
    "contradiction_score": 0.8106319308280945,
    "kept": true
  },
  {
    "clause_index": 12,
    "start_char": 6862,
    "end_char": 6926,
    "original": "\u201cClosing Date \u201d shall mean the date on which the Closing occurs.",
    "ollama_generated": "\"Closing Date\" shall be deemed as the date upon which the occurrence of Closing is first confirmed by the parties in writing. The responsibility for such confirmation rests with the party initiating the closing process, and failure to do so within a reasonable timeframe may result in the delay or termination of the agreement.",
    "contradiction_score": 0.30554112792015076,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 14,
    "start_char": 7000,
    "end_char": 7067,
    "original": "\u201cCompany \u201d shall have the meaning set forth in the recitals hereto.",
    "ollama_generated": "\"For the purpose of this agreement, the term 'Company' shall be construed as defined elsewhere within these documents.\" [This change slightly shifts the responsibility of defining 'Company' to other parts of the document rather than the current clause.]",
    "contradiction_score": 0.056305233389139175,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 15,
    "start_char": 7067,
    "end_char": 7320,
    "original": "\u201cCompany Disclosure Letter \u201d shall mean the letter dated the same date as this Agreement from the Company to the Acquiror disclosing information constituting exceptions to the representations and warranties given by the Company pursuant to Section 3.01.",
    "modified": "\"Acquiror Disclosure Letter\" shall denote the letter dated concurrently with this Agreement from the Acquiror to the Company, disclosing any information that would be an exception to the representations and warranties made by the Acquiror under Section 3.01. In this context, the onus of disclosure shifts from the Company to the Acquiror.",
    "contradiction_score": 0.9421372413635254,
    "kept": true
  },
  {
    "clause_index": 16,
    "start_char": 7322,
    "end_char": 7406,
    "original": "\u201cCompany\u2019s Position Statement \u201d shall have the meaning set forth in Section 2.03(b).",
    "ollama_generated": "\"The definition of 'Company's Position Statement' as outlined in Section 2.03(b) shall govern this Agreement, unless otherwise specified.\"\n\nThis revised clause subtly shifts the responsibility from the reader to explicitly specifying any deviation from the standard definition, while maintaining a professional and fluent tone.",
    "contradiction_score": 0.001405834686011076,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 39,
    "start_char": 12705,
    "end_char": 14736,
    "original": "(i) which is described under \u201cPart 1. Company\u2019s Information \u2013 II. Description of the Company \u2013 5. Material Contracts Relating to Business\u201d in the securities report ( yuka-shoken-hokokusho ) of the Company filed with the Kanto Local Finance Bureau on June 24, 2015 in accordance with Article 24, Paragraph 1 of the FIEL, except for the License Agreement with Astellas Pharma Inc., which is no longer effective\u037e (ii) under which the Company has incurred outstanding Indebtedness, guarantees or Liens, or has assumed other similar obligations\u037e (iii) which will materially limit ability of the Company to compete in any line of business or geographic area or make use of any material Intellectual Property Rights owned by the Company\u037e (iv) relating to the acquisition or disposition of companies or businesses by the Company (whether by purchase or sale of shares or assets, by merger, or otherwise)\u037e (v) under which the Company has made a loan or capital contribution to or any investment in any Person other than the Company\u037e (vi) which establishes or relates to the termination, creation or operation of a joint venture, partnership, or other similar profit (or loss) sharing arrangement\u037e (vii) which requires or restricts the payment of dividends or distributions in respect of the capital stock of the Company\u037e (viii) which was entered into outside the ordinary course of business and which involves obligations or liabilities in excess of [\u2026 ***\u2026] \u037e (ix) which requires the Company or any successor or acquiror of the Company to make any payment to another Person as a result of a change of control of the Company\u037e (x) with any Affiliate, director, executive officer, any holder of 5% or more of the outstanding shares of Common Stock or immediate family members (other than Contracts for stock options)\u037e or which, either as a single Contract or series of related or affiliated Contracts or work orders, constituted one of the 20 largest Contracts of the Company on the basis of revenues generated in the most recent fiscal year.",
    "ollama_generated": "(i) Details provided under \"Part 1. Company\u2019s Information \u2013 II. Description of the Company \u2013 5. Material Contracts Relating to Business\" in the securities report (yuka-shoken-hokokusho) of the Company, submitted to the Kanto Local Finance Bureau on June 24, 2015, in compliance with Article 24, Paragraph 1 of the FIEL, excluding the License Agreement with Astellas Pharma Inc., which is no longer valid; (ii) Agreements under which the Company has incurred outstanding debts, provided guarantees, or secured liens, or taken on other similar obligations; (iii) Contracts that significantly restrict the Company's ability to compete in any business sector or geographic region, or utilize any significant Intellectual Property owned by the Company; (iv) Deals relating to the acquisition or disposal of companies or businesses by the Company (whether by share purchase, asset acquisition, merger, or other means); (v) Agreements under which the Company has provided a loan, capital contribution, or investment to any entity other than itself; (vi) Agreements establishing or concerning the termination, formation, or operation of a joint venture, partnership, or similar profit-sharing arrangement; (vii) Contracts imposing or limiting dividend or distribution payments with respect to the Company's capital stock; (viii) Agreements entered into outside the normal course of business and involving obligations or liabilities exceeding [***...] ; (ix) Requiring the Company, any future successor, or acquirer to make a payment to another party due to a change in control of the Company; (x) with any Affiliate, director, executive officer, holder of 5% or more of the outstanding shares of Common Stock, immediate family members (excluding stock option contracts), or constituting one of the top 20 revenue-generating Contracts for the Company in the most recent fiscal year.\n\nThis revised clause emphasizes certain obligations and conditions, modifies some requirements, and shifts responsibility by excluding stock option contracts from specific agreements. The overall meaning is slightly altered to provide a more flexible interpretation of certain contractual terms.",
    "contradiction_score": 0.012067999690771103,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 41,
    "start_char": 14819,
    "end_char": 14890,
    "original": "\u201cOffer Documents \u201d shall have the meaning set forth in Section 2.02(d).",
    "ollama_generated": "\"The term 'Offer Documents', as defined in Section 2.02(d), may be interpreted subject to any amendments or modifications as deemed necessary by the parties involved.\"",
    "contradiction_score": 0.013899968937039375,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 45,
    "start_char": 15479,
    "end_char": 15545,
    "original": "\u201cOwned Real Property \u201d shall mean the land listed on Schedule III.",
    "ollama_generated": "\"Real Property as Owned \"\" shall encompass any land detailed within Schedule III.\"\n\nExplanation: The original clause specifies a specific set of land (the land listed on Schedule III) as the owned real property. The rewritten clause broadens this definition to include any land that is owned and which may be detailed within Schedule III, implying there might be additional lands not previously considered as part of the owned real property. This change slightly shifts the scope of the property covered by the contract.",
    "contradiction_score": 0.038486991077661514,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 47,
    "start_char": 15724,
    "end_char": 15839,
    "original": "\u201cParties \u201d shall have the meaning set forth in the preamble hereto, and \u201c Party \u201d shall mean either of the Parties.",
    "ollama_generated": "\"For the purpose of this agreement, 'Parties' refers back to the definitions provided in the preface, while 'Either Party' encompasses each of the parties mentioned therein.\"",
    "contradiction_score": 0.0008719115285202861,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 55,
    "start_char": 16862,
    "end_char": 16939,
    "original": "\u201cShare Offer Price \u201d shall have the meaning set forth in the recitals hereto.",
    "ollama_generated": "\"The term '\"Share Offer Price\"' shall be defined only by reference to the recitals contained herein.\"\n\nThis rewording keeps the essence of the original clause but slightly changes its focus, now defining the term exclusively by the recitals in the contract instead of more broadly as \"set forth\".",
    "contradiction_score": 0.006488627754151821,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 61,
    "start_char": 17550,
    "end_char": 17970,
    "original": "\u201cSubsidiaries \u201d shall mean, with respect to any Person, any juridical Person of which more than 50% of the voting power of the outstanding voting securities or more than 50% of the outstanding economic equity interest is held, directly or indirectly, by such Person, and in any event will include any Person that is fully included in the consolidated financial statements of such Person prepared in accordance with GAAP.",
    "modified": "\"Subsidiaries,\" as applied to any Individual or Entity, shall be understood as encompassing any juridical Entity where less than 50% of the voting power of the outstanding voting securities or less than 50% of the outstanding economic equity interest is not held, directly or indirectly, by such Individual or Entity. In all instances, it will exclude any Person that is wholly excluded from the consolidated financial statements of such Individual or Entity prepared in accordance with GAAP.\n\nThis rephrased clause now implies a shift in responsibility as it weakens the control required for an entity to be considered a subsidiary. Instead of requiring more than 50% ownership, the new clause states that less than 50% must not be held by the original Person. Additionally, instead of including any Entity that is included in the consolidated financial statements, the new clause now excludes those Entities.",
    "contradiction_score": 0.8422161936759949,
    "kept": true
  },
  {
    "clause_index": 71,
    "start_char": 20683,
    "end_char": 21223,
    "original": "ARTICLE II TRANSACTION Section 2.01  Strategic Alliance . For the purpose of creating a combined company that can drive considerable growth in global markets, including Japan, the Parties agree to form a strategic business alliance (the \u201c Strategic Business Alliance \u201d) among Acquiror and SPI and its Affiliates (collectively, the \u201c Sucampo Group \u201d) and the Company, subject to the successful Closing. The Parties intend to achieve the purpose of such Strategic Business Alliance by mutual cooperation in, among others, the following areas:",
    "ollama_generated": "ARTICLE II TRANSACTION Section 2.01  Strategic Alliance Amended:\n\nFor the strategic aim of fostering potential growth opportunities globally, including Japan, the Parties opt to establish a business alliance (the \u201cStrategic Business Alliance\u201d) between the Acquiror and SPI, as well as their Affiliates (collectively, the \"Sucampo Group\"), and the Company. The formation of this alliance is contingent upon the successful completion of the transaction (hereafter referred to as the \"Closing\"). While the Sucampo Group will endeavor to facilitate the purpose of such Strategic Business Alliance, it is understood that the primary responsibility for driving growth remains with each individual party. The Parties aim to collaborate in areas such as:\n\n1. Joint research and development initiatives.\n2. Shared marketing strategies and promotional activities.\n3. Combined manufacturing processes, supply chain management, and logistics optimization.\n4. Collaborative efforts in product registration, approval, and distribution.\n5. Exploration of potential synergies across various business operations and functions.\n\nThe Parties reserve the right to amend or discontinue this Strategic Business Alliance should any unforeseen circumstances arise that may affect the partnership's overall success or viability.",
    "contradiction_score": 0.03787580877542496,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 81,
    "start_char": 27702,
    "end_char": 29792,
    "original": "(a) Support of the Offer . Upon the commencement of the Offer, the Company (i) shall, by a unanimous resolution of its board of directors, and with recommendation by the independent committee of the Company, approve a statement of opinion in support of the Offer and recommending the holders of shares of Common Stock and Stock Options to tender their shares and Stock Options to the Offer and have publicly announced such statement, and (ii) shall not revoke such statement. The Company (1) shall also, by a unanimous resolution of its board of directors, and with recommendation by the independent committee of the Company, reveal its intention to support the Squeeze-out and (2) publicly announce such intention, and (3) shall not revoke such intention. Notwithstanding the forgoing, the Company may, upon prior consultation with the Acquiror, revoke or change such statement or intention, only if (A) there is any counter tender offer bid or any bona fide offer to acquire the Target Securities that is a Superior Offer and (B) the failure to take such action, on the basis of legal opinion issued in writing by legal counsel of the Company, would be reasonably expected to cause the board of directors of the Company to be in breach of its duty of care ( zenkan-tyui-gimu ) under Japanese law. For purposes of this Agreement, \u201c Superior Offer \u201d shall mean an unsolicited bona fide  written offer by a third party to purchase all of the outstanding Target Securities that the Board of Directors of the Company determines, in its good faith judgment, after consultation with its outside legal counsel and its financial advisors, is reasonably likely to be consummated in accordance with its terms, taking into account all legal, regulatory and financing aspects (including certainty of closing) of the offer and the ability of the Person making the offer to consummate the transaction and that would result in a transaction more favorable to the Company\u2019s stockholders (solely in their capacity as such) from a financial point of view than the transaction contemplated by this Agreement.",
    "ollama_generated": "(a) Obligations Regarding the Offer. Upon initiation of the Offer, the Company shall:\n\n(i) By a unanimous decision of its board of directors and with a recommendation from an independent committee, issue a statement expressing approval for the Offer and encouraging shareholders of Common Stock and Stock Options to tender their shares and options to the Offer, which statement shall be publicly announced. This approval statement may not be revoked.\n\n(ii) By a unanimous decision of its board of directors and with a recommendation from an independent committee, disclose its intention to support the Squeeze-out, announcing this intention publicly. The Company's intention may also not be revoked. However, the Company retains the discretion to revoke or modify this statement or intention upon consultation with the Acquiror, provided that:\n\n   (A) A counter tender offer or a bona fide offer to acquire Target Securities, which is deemed superior according to the terms of this Agreement, has been made.\n\n   (B) Failing to act, as advised by written legal counsel of the Company, could potentially breach the Company's duty of care under Japanese law.\n\nFor the purposes of this Agreement, a \"Superior Offer\" is defined as an unsolicited, bona fide written proposal made by a third party to purchase all outstanding Target Securities. This offer must be evaluated as being reasonably likely to be completed in accordance with its terms, taking into account all legal, regulatory, and financing aspects (including certainty of closing) of the proposal. The ability of the offering party to complete the transaction, and the potential financial benefit to the Company's shareholders from a financial perspective, must also be considered. If this superior offer results in a more advantageous transaction for the Company's shareholders than that outlined in this Agreement, it shall be deemed a Superior Offer.",
    "contradiction_score": 0.2518540918827057,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 83,
    "start_char": 30173,
    "end_char": 30630,
    "original": "ARTICLE III REPRESENTATIONS AND WARRANTIES Section 3.01  Representations and Warranties of the Company . The Company hereby represents and warrants to Acquiror that, except as disclosed in the Company Disclosure Letter, the statements set forth in Schedule 3.01 are true and correct as of the date of this Agreement and will be true and correct as of the Launch Date and the Closing Date (or, if made as of a specified date, as of such specified date only).",
    "modified": "ARTICLE III REPRESENTATIONS AND WARRANTIES\n   Section 3.01  Representations and Warranties by Acquiror\n\nAcquiror hereby represents and warrants to the Company that, except for those disclosures made in the Acquiror Disclosure Letter, the representations and warranties contained in Schedule 3.01 are accurate and truthful as of the execution date of this Agreement, and shall remain so at the Launch Date and Closing Date (or on any specific date, provided it is only for such specified date).\n\nIn this revised clause, the roles of the parties have been inverted, with the Acquiror now making representations and warranties to the Company, instead of the other way around. The scope of the warranty has also been slightly narrowed by limiting its applicability to specific dates rather than covering any date up until the Closing Date as previously stated.",
    "contradiction_score": 0.6588593125343323,
    "kept": true
  },
  {
    "clause_index": 104,
    "start_char": 48305,
    "end_char": 49054,
    "original": "Section 4.11  Development Programs and Clinical Trials . Following the Closing Date, SPI hereby agrees to engage in a program review in consultation with the management of the Company with respect to the development programs and clinical trials listed in Schedule 4.11, with the goal of [\u2026***\u2026] an [\u2026***\u2026] of [\u2026***\u2026] and [\u2026***\u2026] . Such review shall be conducted consistent with SPI\u2019s process and practices applied to the assessment of its own product candidates, including the [\u2026***\u2026] of a [\u2026***\u2026] of [\u2026***\u2026] on [\u2026***\u2026] of the [\u2026***\u2026]  of [\u2026***\u2026] and [\u2026***\u2026] and the [\u2026***\u2026] for [\u2026***\u2026] , and the [\u2026***\u2026]  at the [\u2026***\u2026] be [\u2026***\u2026] \u037e provided , however , that [\u2026***\u2026] the [\u2026***\u2026] to [\u2026***\u2026] or [\u2026***\u2026] and [\u2026***\u2026] its [\u2026***\u2026] or [\u2026***\u2026] of [\u2026***\u2026] .",
    "ollama_generated": "Section 4.11 Development Programs and Clinical Trials: Post-Closing Date, Acquiring Company (hereafter \"AC\") shall have the option, but not the obligation, to consult with SPI's management regarding the development programs and clinical trials outlined in Schedule 4.11. The goal of such consultation is to explore opportunities for potential collaborations or acquisitions of certain technologies or intellectual properties. This review will be conducted in alignment with AC's standard procedures for evaluating its own product candidates, including but not limited to, the identification of a suitable candidate, assessment of the technology\u2019s feasibility, and determination of the commercial potential. It is understood that any decision made by AC to pursue or refrain from pursuing such opportunities shall be solely at its discretion, without any liability or obligation to SPI.",
    "contradiction_score": 0.38013625144958496,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 112,
    "start_char": 51948,
    "end_char": 52361,
    "original": "Section 6.03  Effect of Termination . In the event of the termination of this Agreement as provided in Section 6.01, this Agreement shall forthwith become void and there shall be no liability on the part of any Party to this Agreement or any Financing Party except as set forth in Article V. This sentence and Section 4.07, Section 4.09, Article V and Article VIII shall survive any termination of this Agreement.",
    "ollama_generated": "Section 6.03 Surviving Obligations upon Termination. Upon the termination of this Agreement as outlined in Section 6.01, each Party to this Agreement and any associated Financing Parties shall incur ongoing liability beyond those specified in Article V. Exclusively, the provisions of this clause, Section 4.07, Section 4.09, Article V, and Article VIII will continue to bind the Parties following the termination of this Agreement.\n\nIn essence, this revised clause strengthens the obligations for each party beyond those specified in Article V after the agreement's termination, whereas the original clause released the parties from any liability apart from that specified in Article V upon termination.",
    "contradiction_score": 0.2044140249490738,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 117,
    "start_char": 53135,
    "end_char": 54866,
    "original": "(b) Notwithstanding anything herein to the contrary, the Parties hereto acknowledge and irrevocably agree (i) that any dispute, action, or proceeding, whether in law or in equity, whether in contract or in tort or otherwise, involving the Lenders arising out of, or relating to, the transactions contemplated hereby, the Financing or the performance of services thereunder or related thereto shall be subject to the exclusive jurisdiction of any state or federal court sitting in the County of New York, Borough of Manhattan, New York, New York and any appellate court thereof and each Party hereto submits for itself and its property with respect to any such dispute, action or proceeding to the exclusive jurisdiction of such court, (ii) not to bring or permit any of their Affiliates to bring or support anyone else in bringing any such dispute, action or proceeding in any other court, (iii) to waive and hereby waive, to the fullest extent permitted by law, any objection which any of them may now or hereafter have to the laying of venue of, and the defense of an inconvenient forum to the maintenance of, any such dispute, action or proceeding in any such court, (iv) to waive and hereby waive any right to trial by jury in respect of any such dispute, action or proceeding, (v) that a final judgment in any such action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law and (vi) that any such dispute, action or proceeding shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to the conflicts of law rules of such State that would result in the application of the laws of any other jurisdiction.",
    "ollama_generated": "(b) Despite anything to the contrary within this agreement, the Parties acknowledge and irrevocably agree as follows:\n\n(i) Any controversy or claim, whether at law or in equity, regarding the Borrowers, arising from or associated with the transactions outlined herein, the Loan, or services related thereto, will be subject to the non-exclusive jurisdiction of any state or federal court located within the County of New York, Borough of Manhattan, New York, New York. Each Party submits to such jurisdiction for itself and its assets in relation to any such controversy or claim.\n\n(ii) They will not instigate or allow their Affiliates to initiate or support others in bringing any such controversy or claim in any court other than those specified above.\n\n(iii) They waive, to the fullest extent legally permissible, any objection to the venue of, and inconvenience of forum for, any such controversy or claim in any such court.\n\n(iv) They relinquish and hereby waive any right to a trial by jury regarding any such controversy or claim.\n\n(v) A final judgment in any such action shall be enforceable in other jurisdictions by suit on the judgment or any other legal means provided.\n\n(vi) Any such controversy or claim will be interpreted, applied, and resolved in accordance with the laws of the State of New York, except for its conflict-of-laws rules that might apply the laws of another jurisdiction. This provision does not establish a basis for personal jurisdiction over any Party for any purpose other than as expressly provided in this agreement.",
    "contradiction_score": 0.18505698442459106,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 123,
    "start_char": 57210,
    "end_char": 57458,
    "original": "Section 8.07  Counterparts . This Agreement may be executed in two or more counterparts (including by facsimile or email pdf format), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.",
    "ollama_generated": "Section 8.07 Execution in Multiple Forms: This Agreement can be executed as a single instrument through multiple signed originals, including facsimile or email pdf versions. Each such execution shall be considered valid and binding, with all collective parts forming a unified whole.\n\nThis version clarifies that each part of the agreement is considered valid and binding individually, while maintaining the integrity of the overall document as a single instrument.",
    "contradiction_score": 0.02739063836634159,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 128,
    "start_char": 58944,
    "end_char": 59064,
    "original": "2-2-16, Sonezakishinchi, Kita-ku, Osaka Attention: [\u2026***\u2026] Phone: [\u2026***\u2026] Fax: [\u2026***\u2026] Email address: [\u2026***\u2026] If to SPI:",
    "ollama_generated": "2-2-16, Sonezakishinchi, Kita-ku, Osaka\nAttention: [\u2026***\u2026]\nPhone: [\u2026***\u2026]\nFax: [\u2026***\u2026]\nEmail address: [\u2026***\u2026]\nIf receiving correspondence from SPI:\n\nIn the event that correspondence is received from SPI, it shall be our responsibility to promptly review such communication and respond within a reasonable timeframe. However, we reserve the right to seek clarification or additional information as necessary to ensure a thorough understanding of any inquiries or instructions. In the event that we are unable to fulfill an obligation set forth in said correspondence due to unforeseen circumstances beyond our control, we will make every effort to communicate this to SPI in a timely manner and work collaboratively to find a mutually agreeable solution.",
    "contradiction_score": 0.019429165869951248,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 131,
    "start_char": 59242,
    "end_char": 59259,
    "original": "R-Tech Ueno, Ltd.",
    "ollama_generated": "Shifted Responsibility: In the event that any dispute arises between the parties regarding this Agreement, the party initially claiming a breach shall bear the initial responsibility for resolving such dispute through good faith negotiations. If said dispute remains unresolved after a reasonable period of time, the party initially claiming a breach may seek resolution through binding arbitration, subject to the Commercial Arbitration Rules of the International Chamber of Commerce.",
    "contradiction_score": 0.14546430110931396,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 140,
    "start_char": 62281,
    "end_char": 62339,
    "original": "By: /s/ Y. Mashima Name: Yukihiko Mashima Title: President",
    "ollama_generated": "By: /s/ Y. Mashima Name: Yukihiko Mashima Title: President (Designated Representative)\n\nNew Clause:\nIn the event that the primary obligations herein are not fully complied with by any party, the aggrieved party shall have the discretionary power to remedy the situation through reasonable efforts, or seek a resolution through mutually agreed-upon mediation, without an obligation to immediately terminate this agreement. The non-compliant party shall bear no liability for damages arising from such attempts at resolution unless proven to have acted in gross negligence or willful misconduct.",
    "contradiction_score": 0.05687795206904411,
    "kept": false,
    "reason": "low_contradiction"
  }
]